INS and type 1 diabetes mellitus: A previous meta-analysis, including 11 randomized controlled trials (RCTs) that used liraglutide, exenatide, or albiglutide has shown that adjunctive therapy with GLP-1RA in T1D leads to improvement in HbA1c, weight loss, and decrease in total daily insulin dose (TID) [11].